Canadian Journal of Gastroenterology (Jan 2010)

Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy

  • Kaveh Sharzehi,
  • Mary Ann Huang,
  • Ian R Schreibman,
  • Kimberly A Brown

DOI
https://doi.org/10.1155/2010/891252
Journal volume & issue
Vol. 24, no. 10
pp. 588 – 592

Abstract

Read online

BACKGROUND: Autoimmune hepatitis is characterized by hepatocellular inflammation often progressing to cirrhosis. Standard treatment consists of corticosteroids and azathioprine. For the 20% of patients with refractory disease or those who are intolerant to medication, there is no standardized treatment.